A Single Ascending Dose Cohort Study of AG-73305 in DME Patients

Clinical trial NCT05301751 · COMPLETED

Trial details

NCT number: NCT05301751
Sponsor: Allgenesis Biotherapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2022-05-19
Primary completion: 2023-09-28
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.